Superactive GnRH agonists are the most potent inhibitors of gonadal function. Administered over a few days, they markedly inhibit LH and FSH release, resulting in loss of androgen secretion.
IMPEDED ANDROGENS / ANTIANDROGENS
Superactive GnRH agonists are the most potent
inhibitors of gonadal function.
Administered over a few days, they markedly inhibit LH and FSH release, resulting
in loss of androgen secretion.
Ketoconazole at high doses inhibits
steroidogenic CYP 450 enzymes: testosterone
as well as adrenal steroid production is interfered. Plasma protein binding of
testosterone is also reduced. However, toxicity of high doses precludes its use
to suppress androgens.
Cimetidine and spironolactone have weak antiandrogenic action which manifests as side effects.
Progesterone has weak androgen
receptor blocking action.
Drugs that have been
clinically used to modify androgen action are:
It is an orally active
ethisterone derivative having weak
androgenic, anabolic and progestational activities. Though labelled as an
impeded/attenuated androgen, because it binds to the androgen receptor and
induces some androgenspecific mRNA production, the most prominent action is
suppression of Gn secretion from pituitary in both men and women → inhibition of
testicular/ovarian function. It suppresses gonadal function directly as well by
inhibiting steroidogenic enzymes. Endometrial atrophy occurs over few a weeks
and amenorrhoea may supervene. Danazol is metabolized with a t½ of 12–18 hours.
Dose: 200–600 mg/day; DANAZOL, LADOGAL, DANOGEN, GONABLOK 50, 100, 200 mg cap.
Uses are:
Danazol causes marked improvement in ~75% cases. Relief of dysmenorrhoea
is prompt. Pain, dyspareunia and excessive bleeding regress slowly. After a 3–6
month course, prolonged relief occurs in over half of the patients. Severe
cases derive incomplete relief. Androgenic side effects are the limiting
feature, because of which use has declined.
It reduces menstrual blood loss. Usually complete amenorrhoea does not occur
with 200 mg/day. When withdrawn after 3 months therapy—blood loss continues to
be smaller than previously in many cases.
3–6 months treatment causes improvement with
decrease in pain, nodularity and engorgement in 75% cases.
Withdrawal of danazol
after 3 month treatment results in resumption of ovulation and rebound
fertility in some women; pregnancy rate is increased in the subsequent 6
months.
Side Effects are frequent and dose related. Complete amenorrhoea occurs with higher doses
as long as drug is given. Occasional spotting may be seen in some.
Androgenic side
effects are acne, hirsutism, decreased breast size, deepening of voice, edema
and weight gain. Loss of libido in men, hot flashes in women and night sweats,
muscle cramps, g.i. upset, elivation of hepatic enzymes are the other side effects.
It
is chemically related to progesterone—has progestational activity which
inhibits LH release augmenting the direct antiandrogenic action. More
importantly, it competes with dihydrotestosterone for the intracellular
androgen receptor and inhibits its binding. Larger doses prevent pubertal changes
while in the adult libido and androgenic anabolism are lost, gynaecomastia can
occur.
Cyproterone
has been clinically tested in precocious puberty in boys, inappropriate sexual
behaviour in men, acne and virilization in women, but is not marketed.
A nonsteroidal drug
having specific antiandrogenic, but no
other hormonal activity. Its active metabolite 2hydroxyflutamide competitively
blocks androgen action on accessory sex organs as well as on
pituitary—increases LH secretion by blocking feedback inhibition. Plasma
testosterone levels increase in males which partially overcome the direct
antiandrogenic action. Palliative effect may occur in metastatic prostatic
carcinoma, but it is better used in conjunction with a GnRH agonist (to suppress
LH and testosterone secretion) or after castration to block residual action of
adrenal androgens. Along with oral contraceptives it has been tried in female
hirsutism. Though gynaecomastia and breast tenderness occur frequently, libido
and potency are largely preserved. Reports of liver damage have restricted its
use.
Dose: 250 mg TDS; PROSTAMID, FLUTIDE,
CYTOMID 250 mg tab.
This
more potent and longer acting congener of
flutamide is suitable for once daily administration in metastatic carcinoma of
prostate. When used along with a GnRH agonist or castration, 50 mg OD affords
marked relief in bone pain and other symptoms due to the metastasis. Side effects
are hot flashes, chills, edema and loose stools, but it is better tolerated and
less hepatotoxic than flutamide. Elevation of hepatic transaminase above twice
normal is a signal for stopping the drug.
BIPROSTA, CALUTIDE,
TABI 50 mg tab.
Related Topics
TH 2019 - 2025 pharmacy180.com; Developed by Therithal info.